Inversed relationship between CD44 variant and c-Myc due to oxidative stress-induced canonical Wnt activation

Biochemical and Biophysical Research Communications

Volumn 443, Issue 2, 2014, Pages 622-627

  Yoshida, Go J ^a   Saya, Hideyuki ^a  

^a KEIO UNIVERSITY   (Japan)

Author keywords

c Myc; Cancer stem like cell; CD44 variant; Fbw7; Gastric cancer; Redox stress induced Wnt signal

Indexed keywords

CD44V ANTIGEN; MYC PROTEIN; WNT PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER CELL; CANCER STEM CELL; CELL POPULATION; CELL PROLIFERATION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; MOUSE; NONHUMAN; ONCOGENE; ONCOGENE C MYC; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STOMACH CANCER; UPREGULATION; WESTERN BLOTTING; WNT SIGNALING PATHWAY;

C-MYC; CANCER STEM-LIKE CELL; CD44 VARIANT; FBW7; GASTRIC CANCER; REDOX STRESS-INDUCED WNT SIGNAL;

ANTIGENS, CD44; CELL LINE, TUMOR; GENETIC VARIATION; HUMANS; NEOPLASTIC STEM CELLS; OXIDATIVE STRESS; PROTO-ONCOGENE PROTEINS C-MYC; WNT PROTEINS;

EID: 84892432945     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2013.12.016     Document Type: Article

References (39)

1. K.R. Martin, and J.C. Barrett Reactive oxygen species as double-edged swords in cellular processes: low-dose cell signaling versus high-dose toxicity Hum. Exp. Toxicol. 21 2002 71 75
2. J.S. Pan, M.Z. Hong, and J.L. Ren Reactive oxygen species: a double-edged sword in oncogenesis World J. Gastroenterol. 15 2009 1702 1707
3. A. Kikuchi Regulation of beta-catenin signaling in the Wnt pathway Biochem. Biophys. Res. Commun. 268 2000 243 248
4. H. Korkaya, and M.S. Wicha Cancer stem cells: nature versus nurture Nat. Cell Biol. 12 2010 419 421
5. Y. Funato, T. Michiue, M. Asashima, and H. Miki The thioredoxin-related redox-regulating protein nucleoredoxin inhibits Wnt-beta-catenin signalling through dishevelled Nat. Cell Biol. 8 2006 501 508
6. M. Zoller CD44: can a cancer-initiating cell profit from an abundantly expressed molecule? Nat. Rev. Cancer 11 2011 254 267
7. R.L. Brown, L.M. Reinke, M.S. Damerow, D. Perez, L.A. Chodosh, J. Yang, and C. Cheng CD44 splice isoform switching in human and mouse epithelium is essential for epithelial-mesenchymal transition and breast cancer progression J. Clin. Invest. 121 2011 1064 1074
8. R. Kalluri, and R.A. Weinberg The basics of epithelial-mesenchymal transition J. Clin. Invest. 119 2009 1420 1428
9. T. Ishimoto, O. Nagano, T. Yae, M. Tamada, T. Motohara, H. Oshima, M. Oshima, T. Ikeda, R. Asaba, H. Yagi, T. Masuko, T. Shimizu, T. Ishikawa, K. Kai, E. Takahashi, Y. Imamura, Y. Baba, M. Ohmura, M. Suematsu, H. Baba, and H. Saya CD44 variant regulates redox status in cancer cells by stabilizing the xCT subunit of system xc(-) and thereby promotes tumor growth Cancer Cell 19 2011 387 400
10. S. Hasenauer, D. Malinger, D. Koschut, G. Pace, A. Matzke, A. von Au, and V. Orian-Rousseau Internalization of Met requires the co-receptor CD44v6 and its link to ERM proteins PLoS One 8 2013 e62357
11. J. Shi, Z. Zhou, W. Di, and N. Li Correlation of CD44v6 expression with ovarian cancer progression and recurrence BMC Cancer 13 2013 182
12. J.P. Medema Cancer stem cells: the challenges ahead Nat. Cell Biol. 15 2013 338 344
13. R.M. Castilho, C.H. Squarize, L.A. Chodosh, B.O. Williams, and J.S. Gutkind MTOR mediates Wnt-induced epidermal stem cell exhaustion and aging Cell Stem Cell 5 2009 279 289
14. Y. Ruzankina, and E.J. Brown Relationships between stem cell exhaustion, tumour suppression and ageing Br. J. Cancer 97 2007 1189 1193
15. A. Wilson, M.J. Murphy, T. Oskarsson, K. Kaloulis, M.D. Bettess, G.M. Oser, A.C. Pasche, C. Knabenhans, H.R. Macdonald, and A. Trumpp c-Myc controls the balance between hematopoietic stem cell self-renewal and differentiation Genes Dev. 18 2004 2747 2763
16. J.M. Perry, and L. Li Self-renewal versus transformation: Fbxw7 deletion leads to stem cell activation and leukemogenesis Genes Dev. 22 2008 1107 1109
17. Z. Wang, H. Inuzuka, H. Fukushima, L. Wan, D. Gao, S. Shaik, F.H. Sarkar, and W. Wei Emerging roles of the FBW7 tumour suppressor in stem cell differentiation EMBO Rep. 13 2012 36 43
18. W. Lou, D. Krill, R. Dhir, M.J. Becich, J.T. Dong, H.F. Frierson Jr., W.B. Isaacs, J.T. Isaacs, and A.C. Gao Methylation of the CD44 metastasis suppressor gene in human prostate cancer Cancer Res. 59 1999 2329 2331
19. S. Sato, H. Yokozaki, W. Yasui, H. Nikai, and E. Tahara Silencing of the CD44 gene by CpG methylation in a human gastric carcinoma cell line Jpn. J. Cancer Res. 90 1999 485 489
20. G. Suriano, N. Vrcelj, J. Senz, P. Ferreira, H. Masoudi, K. Cox, S. Nabais, C. Lopes, J.C. Machado, R. Seruca, F. Carneiro, and D.G. Huntsman Beta-catenin (CTNNB1) gene amplification: a new mechanism of protein overexpression in cancer Genes Chromosomes Cancer 42 2005 238 246
21. Y. Cheng, and G. Li Role of the ubiquitin ligase Fbw7 in cancer progression Cancer Metastasis Rev. 31 2012 75 87
22. S.M. Karam, and C.P. Leblond Dynamics of epithelial cells in the corpus of the mouse stomach. I. Identification of proliferative cell types and pinpointing of the stem cell Anat. Rec. 236 1993 259 279
23. E.R. Lee, and C.P. Leblond Dynamic histology of the antral epithelium in the mouse stomach: II. Ultrastructure and renewal of isthmal cells Am. J. Anat. 172 1985 205 224
24. J.C. Mills, and R.A. Shivdasani Gastric epithelial stem cells Gastroenterology 140 2011 412 424
25. N. Barker, M. Huch, P. Kujala, M. van de Wetering, H.J. Snippert, J.H. van Es, T. Sato, D.E. Stange, H. Begthel, M. van den Born, E. Danenberg, S. van den Brink, J. Korving, A. Abo, P.J. Peters, N. Wright, R. Poulsom, and H. Clevers Lgr5(+ve) stem cells drive self-renewal in the stomach and build long-lived gastric units in vitro Cell Stem Cell 6 2010 25 36
26. H. Oshima, A. Matsunaga, T. Fujimura, T. Tsukamoto, M.M. Taketo, and M. Oshima Carcinogenesis in mouse stomach by simultaneous activation of the Wnt signaling and prostaglandin E2 pathway Gastroenterology 131 2006 1086 1095
27. E.V. Schmidt The role of c-myc in cellular growth control Oncogene 18 1999 2988 2996
28. D. Cappellen, T. Schlange, M. Bauer, F. Maurer, and N.E. Hynes Novel c-MYC target genes mediate differential effects on cell proliferation and migration EMBO Rep. 8 2007 70 76
29. M.H. Faria, B.P. Goncalves, R.M. do Patrocinio, M.O. de Moraes-Filho, and S.H. Rabenhorst Expression of Ki-67, topoisomerase IIalpha and c-MYC in astrocytic tumors: correlation with the histopathological grade and proliferative status Neuropathology 26 2006 519 527
30. B. Banky, L. Raso-Barnett, T. Barbai, J. Timar, P. Becsagh, and E. Raso Characteristics of CD44 alternative splice pattern in the course of human colorectal adenocarcinoma progression Mol. Cancer 11 2012 83
31. E. Olsson, G. Honeth, P.O. Bendahl, L.H. Saal, S. Gruvberger-Saal, M. Ringner, J. Vallon-Christersson, G. Jonsson, K. Holm, K. Lovgren, M. Ferno, D. Grabau, A. Borg, and C. Hegardt CD44 isoforms are heterogeneously expressed in breast cancer and correlate with tumor subtypes and cancer stem cell markers BMC Cancer 11 2011 418
32. V.S. Donnenberg, A.D. Donnenberg, L. Zimmerlin, R.J. Landreneau, R. Bhargava, R.A. Wetzel, P. Basse, and A.M. Brufsky Localization of CD44 and CD90 positive cells to the invasive front of breast tumors Cytometry B Clin. Cytom. 78 2010 287 301
33. G.F. Le Bras, G.L. Allison, N.F. Richards, S.S. Ansari, M.K. Washington, and C.D. Andl CD44 upregulation in E-cadherin-negative esophageal cancers results in cell invasion PLoS One 6 2011 e27063
34. M. Uchino, H. Kojima, K. Wada, M. Imada, F. Onoda, H. Satofuka, T. Utsugi, and Y. Murakami Nuclear beta-catenin and CD44 upregulation characterize invasive cell populations in non-aggressive MCF-7 breast cancer cells BMC Cancer 10 2010 414
35. M. Ibusuki, Y. Yamamoto, S. Shinriki, Y. Ando, and H. Iwase Reduced expression of ubiquitin ligase FBXW7 mRNA is associated with poor prognosis in breast cancer patients Cancer Sci. 102 2011 439 445
36. S. Yamamoto, M. Yamamoto-Ibusuki, Y. Yamamoto, S. Fujiwara, and H. Iwase A comprehensive analysis of Aurora A; transcript levels are the most reliable in association with proliferation and prognosis in breast cancer BMC Cancer 13 2013 217
37. J.V. Alvarez, T.C. Pan, J. Ruth, Y. Feng, A. Zhou, D. Pant, J.S. Grimley, T.J. Wandless, A. Demichele, and L.A. Chodosh Par-4 downregulation promotes breast cancer recurrence by preventing multinucleation following targeted therapy Cancer Cell 24 2013 30 44
38. M. Maugeri-Sacca, M. Bartucci, and R. De Maria DNA damage repair pathways in cancer stem cells Mol. Cancer Ther. 11 2012 1627 1636
39. R. Weinberg, D.E. Fisher, and J. Rich Dynamic and transient cancer stem cells nurture melanoma Nat. Med. 16 2010 758